Teton Advisors’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.02M Hold
53,000
1.42% 19
2025
Q4
$1.16M Sell
53,000
-5,000
-9% -$104K 0.8% 41
2025
Q3
$1.25M Buy
58,000
+8,000
+16% +$179K 0.77% 39
2025
Q2
$1.28M Hold
50,000
0.78% 33
2025
Q1
$1.83M Sell
50,000
-1,000
-2% -$34.4K 1.14% 22
2024
Q4
$1.56M Hold
51,000
0.8% 35
2024
Q3
$1.92M Sell
51,000
-2,000
-4% -$77.1K 0.86% 26
2024
Q2
$2.1M Hold
53,000
0.88% 27
2024
Q1
$1.78M Hold
53,000
0.63% 40
2023
Q4
$1.77M Sell
53,000
-10,000
-16% -$323K 0.58% 49
2023
Q3
$1.98M Hold
63,000
0.61% 43
2023
Q2
$2M Hold
63,000
0.56% 49
2023
Q1
$2.08M Hold
63,000
0.55% 51
2022
Q4
$2.03M Hold
63,000
0.52% 53
2022
Q3
$2.25M Buy
63,000
+10,500
+20% +$436K 0.55% 45
2022
Q2
$2.16M Buy
52,500
+2,500
+5% +$121K 0.46% 60
2022
Q1
$2.9M Hold
50,000
0.5% 56
2021
Q4
$2.94M Hold
50,000
0.42% 65
2021
Q3
$3.04M Hold
50,000
0.44% 59
2021
Q2
$3M Hold
50,000
0.4% 64
2021
Q1
$2.36M Buy
50,000
+17,000
+52% +$700K 0.33% 78
2020
Q4
$1.24M Buy
+33,000
New +$1.09M 0.17% 150

Other funds holding ATEX

Teton Advisors's ATEX Position: Q1 2026 in Review

Teton Advisors held its Anterix (ATEX) position steady in Q1 2026 at 53,000 shares worth $2.02M. The position accounts for 1.42% of the portfolio, ranked #19.

Teton Advisors first reported a position in ATEX in Q4 2020 and has held it in 22 quarters since. The position peaked at $3.04M in Q3 2021. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Teton Advisors held 53,000 shares of Anterix worth $2.02M as of Q1 2026.
  • Teton Advisors left its Anterix share count unchanged in Q1 2026.
  • Anterix made up 1.42% of Teton Advisors's portfolio in Q1 2026, its #19 holding.
  • Teton Advisors first reported a position in Anterix in Q4 2020 and has held it in 22 quarters since.
  • Teton Advisors's Anterix position peaked at $3.04M in Q3 2021.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Teton Advisors's 13F filing for Q1 2026, filed 14 May 2026.